Latest News about DEA
Recent news which mentions DEA
   4 Analysts Have This to Say About Easterly Government Props
   
  November 03, 2022
  Tickers 
   DEA
  
  
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022
   
  
  
  November 03, 2022
  From Benzinga
 
   DEA's Consistent Denial Of Psilocybin Access For Terminally Ill Being Challenged Again
   
  
  
  October 27, 2022
  From Benzinga
 
   3 Top Dividend Stocks to Buy and Hold in 2023
   
  
  
  October 25, 2022
  From Motley Fool
 
   3 High-Yield Dividend Stocks That Could Be Passive-Income Machines
   
  
  
  October 22, 2022
  From Motley Fool
 
   3 Attractive REITs With A Dividend Yield Over 6%
   
  
  
  October 13, 2022
  From Benzinga
 
   3 Ridiculously Cheap High-Yield Dividend Stocks
   
  
  
  October 12, 2022
  From Motley Fool
 
   DEA-Licensed Pharmaceutical Cannabis Research Company Announces $20M Series A Funding Round
   
  
  
  October 04, 2022
  From Benzinga
 
   DEA's Alarming Fentanyl Seizure, Nevada's Nearly $1B In Sales, Oregon Raids Yield Hefty Fines & More
   
  
  
  October 04, 2022
  From Benzinga
 
   DEA Claims Doctors Requesting Psilocybin For Dying Patients Have Commercial Interests
   
  September 29, 2022
  Tickers 
   DEA
  
  
  From Benzinga
 
   Congressional Psychedelics Talks: Comments By Officials In Favor, Including Rep. Blumenauer And AOC
   
  
  
  September 22, 2022
  From Benzinga
 
   What 4 Analyst Ratings Have To Say About Easterly Government Props
   
  September 14, 2022
  Tickers 
   DEA
  
  
  From Benzinga
 
   3 High-Yield Dividend Stocks to Buy in September Without Any Hesitation
   
  
  
  September 03, 2022
  From Motley Fool
 
   Fetterman Calls On Biden To Decriminalize Cannabis, But White House Defers To States
   
  August 30, 2022
  Tickers 
   DEA
  
  
  From Benzinga
 From MarketWatch
 
   DEA Psychedelic Drugs Banning Attempt: These Are The Two Hallucinogens Under Discussion
   
  August 23, 2022
  Tickers 
   DEA
  
  
  From Benzinga
 
   CNBC's Final Trades: Easterly Government Properties, ExxonMobil, Illinois Tool Works And This Health Care Company
   
  
  
  August 18, 2022
  From Benzinga
 
   Apple, IBM Are CNBC 'Fast Money' Calls Of The Day
   
  
  
  August 17, 2022
  From Benzinga
 
   BREAKING: Cybin And Clinilabs Receive DEA License For First-In-Human Clinical Trial Of Psilocybin To Treat Depression
   
  
  
  August 17, 2022
  From Benzinga
 
   3 Dividend Stocks to Buy Right Now Without Any Hesitation
   
  
  
  August 14, 2022
  From Motley Fool
 
   Senate Marijuana & Psychedelics Reforms: Appropriations Committee Chair Patrick Leahy Marks 12 Bills For FY 2023
   
  August 01, 2022
  Tickers 
   DEA
  
  
  From Benzinga
 
   3 High-Yield Dividend Stocks to Buy in August
   
  
  
  August 01, 2022
  From Motley Fool
 
   DEA Reports Uptick In Marijuana-Related Seizures & Arrests: Why Is This Happening? NORML Has An Idea
   
  June 16, 2022
  Tickers 
   DEA
  
  
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.